NCT00947843

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Assessment of the Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents : A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 306 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficacy and tolerability between clopidogrel resinate and clopidogrel bisulfate in patients with coronary heart disease (CHD) or CHD equivalents.

Conditions

• Coronary Heart Disease

Interventions

Type	Name	Description
DRUG	aspirin + pregrel (Clopidogrel resinate)
DRUG	aspirin + placebo
DRUG	aspirin + plavix (Clopidogrel bisulfate)

Timeline

• Start date: 2013-11-01
• Primary completion: 2016-10-01
• Completion: 2016-10-01
• First posted: 2009-07-28
• Last updated: 2016-10-13